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injury. However, this approach is not risk-free, and the underlying pro-
tectivemechanisms are poorly understood. In this issue of EbioMedicine,
Rzechorzek et al. (2015) have studied the neuroprotective mechanisms
induced by hypothermic preconditioning in functional cortical neurons
differentiated from human pluripotent stem cells. They found that mild
or moderate hypothermia induced an endoplasmic reticulum (ER)
stress response and activation of the unfolded protein response (UPR),
which are the cellular mechanisms that ensure correct folding of
newly synthesized secreted and membrane proteins before they exit
the ER (Hetz and Mollereau, 2014). This response was sufﬁcient to pro-
tect the cells tomore severe stress – an effect known as ER hormesis – in
this case, to subsequent treatmentwith oxidative and ER stressors. Inhi-
bition of the UPR during hypothermic preconditioning abrogated the
protective response. Thus, exposure of the cortical neurons to cold stress
prompted a UPR-dependent adaptive response that protected against
oxidative and ER stresses.
How hypothermia induces the UPR and ER hormesis is unknown.
One possibility is that it is simply due to aberrant folding of as yet un-
known proteins at low temperatures. Alternatively, hypothermia may
induce cold shock proteins such as the RNA binding motif protein 3
(RBM3), which has recently been shown to confer neuroprotection by
increasing structural plasticity at the level of synapses (Peretti et al.,
2015).
Restoration of protein homeostasis following ER stress requires acti-
vation of the three arms of the UPR, initiated by IRE1 (inositol-requiring
enzyme 1), ATF6 (activating transcription factor 6), and PERK (protein
kinase RNA-like endoplasmic reticulumkinase). These pathways induce
expression of chaperone proteins to facilitate protein folding, attenuate
translation and trigger ER-associated degradation (ERAD) to remove
aberrantly folded proteins.
Interestingly, Rzechorzek et al. found that although cold stress acti-
vated the PERK pathway, induction of the downstream transcription
factor CHOP did not lead to expression of Bax or to apoptosis. Instead,
they found that PERK inhibitors abrogated the neuroprotection
conferred by cold stress. This indicates that PERK contributes to the
adaptive response induced by cold stress, possibly by stimulating an an-
tioxidant response.
These results are particularly timely given the growing interest in
the function of ER stress in physiological and pathological conditionsDOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.04.004.
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tioning is neuroprotective. For example, mutations in the chaperone
ninaA induce an adaptive UPR-dependent response that protects
Drosophila photoreceptor neurons (Mendes et al., 2009). This study
was the ﬁrst to use the term ER hormesis as an extension of the
hormesis paradigm, which posits that exposure to a low dose of a
toxic chemical agent or environmental factor induces an adaptive ben-
eﬁcial response that protects the cell or organism when exposed to
higher doses of the agent (Calabrese et al., 2010). ER hormesis can
also be elicited by treatment with the ER stress inducer tunicamycin,
which confers neuroprotection by stimulating an autophagic response
in Drosophila, mouse, and human neuroblastomamodels of Parkinson's
disease (Fouillet et al., 2012).
In empirical medicine, the concept thatmild stress can be protective
is not new. As Nietzsche said: “What does not kill youmakes you stron-
ger”. For example, rapid cycles of ischemia are used to precondition the
heart before surgery. Although the protective mechanisms behind the
hormetic response are poorly understood, they have largely been attrib-
uted to increases in the levels of reactive oxygen species (ROS) in mito-
chondria following exposure to mild stress, which are thought to then
trigger a protective antioxidant response (Luna-Lopez et al., 2014).
Thus, identiﬁcation of the mechanisms and targets that mediate hypo-
thermic ER hormesis and other forms of hormetic tissue protection
should mitigate the risks of preconditioning interventions while pre-
serving their therapeutic effects.
Currently, there is intense focus on identifying molecules that can
modulate the UPR (Hetz et al., 2013). Since the UPR can stimulate
both pro- and anti-survival pathways, pharmacological modulation of
the UPR could be used either to stimulate ER hormesis, which might
be beneﬁcial in treating neurodegenerative diseases, or to induce
apoptosis, which could be useful for cancer treatment. A wide range of
molecules has been developed that inhibit the pro-survival function of
the UPR, and many have been used in preclinical or clinical studies in
cancer. Fewer compounds have been shown to increase the UPR and
ER folding capacity (Hetz et al., 2013). Tunicamycin is a broad inducer
of UPR pathways, but more speciﬁc activating drugs have shown bene-
ﬁcial effects in models of neurodegeneration (Fouillet et al., 2012; Hetz
et al., 2013). Examples include salubrinal and guanabenz, which in-
crease phosphorylation of eIF2α by inactivating eIF2α phosphatase
complexes. Salubrinal can reduce both neuronal cell death after
excitotoxicity in the hippocampus and neurodegeneration in models
of Parkinson disease and amyotrophic lateral sclerosis. Quercetin, an-
other interesting candidate, activates IRE1 by speciﬁcally interacting
with the IRE Ken domain (Wiseman et al., 2010). The goal of futurethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
483B. Mollereau / EBioMedicine 2 (2015) 482–483research will be to further characterize the protective pathways of the
UPR and to identify speciﬁc drugs capable of stimulating an adaptive
ER stress response with minimal adverse side effects.
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